Title of Collaborative Activity: |
Critical Path to TB Drug Regimens (CPTR) Rapid Drug Sensitivity Testing (DST) Consortium |
Description of Collaborative Activity: |
The purpose of the CPTR Rapid DST Consortium to support and sustain discussion, information sharing, and decision making to coordinate clinical trials of new TB drug combinations. The overall goal is to advance new therapies rapidly and cost-effectively while maintaining the highest standards of scientific rigor. The Consortium will work to coordinate planning among the major non-commercial sponsors and their research groups to ensure rapid and efficient Phase II evaluations of drug combinations. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2012 |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID |
HHS Agency Collaborators on this Activity: |
CDC |
